1. Home
  2. ANVS vs SURG Comparison

ANVS vs SURG Comparison

Compare ANVS & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • SURG
  • Stock Information
  • Founded
  • ANVS 2008
  • SURG 2006
  • Country
  • ANVS United States
  • SURG United States
  • Employees
  • ANVS N/A
  • SURG N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • SURG Advertising
  • Sector
  • ANVS Health Care
  • SURG Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • SURG Nasdaq
  • Market Cap
  • ANVS 54.6M
  • SURG 56.5M
  • IPO Year
  • ANVS 2020
  • SURG N/A
  • Fundamental
  • Price
  • ANVS $2.64
  • SURG $2.70
  • Analyst Decision
  • ANVS Strong Buy
  • SURG Strong Buy
  • Analyst Count
  • ANVS 5
  • SURG 1
  • Target Price
  • ANVS $30.25
  • SURG $9.00
  • AVG Volume (30 Days)
  • ANVS 570.5K
  • SURG 84.4K
  • Earning Date
  • ANVS 08-14-2025
  • SURG 08-12-2025
  • Dividend Yield
  • ANVS N/A
  • SURG N/A
  • EPS Growth
  • ANVS N/A
  • SURG N/A
  • EPS
  • ANVS N/A
  • SURG N/A
  • Revenue
  • ANVS N/A
  • SURG $40,029,467.00
  • Revenue This Year
  • ANVS N/A
  • SURG $124.78
  • Revenue Next Year
  • ANVS N/A
  • SURG $49.21
  • P/E Ratio
  • ANVS N/A
  • SURG N/A
  • Revenue Growth
  • ANVS N/A
  • SURG N/A
  • 52 Week Low
  • ANVS $1.11
  • SURG $1.05
  • 52 Week High
  • ANVS $17.88
  • SURG $3.52
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 54.28
  • SURG 47.31
  • Support Level
  • ANVS $2.73
  • SURG $2.70
  • Resistance Level
  • ANVS $3.08
  • SURG $2.95
  • Average True Range (ATR)
  • ANVS 0.32
  • SURG 0.17
  • MACD
  • ANVS -0.06
  • SURG -0.03
  • Stochastic Oscillator
  • ANVS 29.41
  • SURG 27.91

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

Share on Social Networks: